Kokonozaki M - Search Results

1

Circulating serum levels of IL-20 in multiple myeloma patients: its significance in angiogenesis and disease activity.

Alexandrakis MG, Pappa CA, Kokonozaki M, Boula A, Vyzoukaki R, Staphylaki D, Papadopoulou A, Androulakis N, Tsirakis G, Sfiridaki A. Alexandrakis MG, et al. Among authors: kokonozaki m. Med Oncol. 2015 Mar;32(3):42. doi: 10.1007/s12032-015-0488-z. Epub 2015 Jan 29. Med Oncol. 2015. PMID: 25631632 Clinical Trial.

2

Potential role of FLT3-ligand in the angiogenic process of multiple myeloma.

Kokonozaki M, Tsirakis G, Devetzoglou M, Kyriakaki S, Antonakis A, Vyzoukaki R, Pappa CA, Tzardi M, Alexandrakis MG. Kokonozaki M, et al. Leuk Res. 2015 Dec;39(12):1467-72. doi: 10.1016/j.leukres.2015.10.009. Epub 2015 Oct 20. Leuk Res. 2015. PMID: 26521986

3

Immunohistochemical expression of endoglin offers a reliable estimation of bone marrow neoangiogenesis in multiple myeloma.

Alexandrakis MG, Neonakis IK, Pappa CA, Konsolas I, Kokonozaki M, Vyzoukaki R, Soundoulounaki S, Xekalou A, Sfiridaki K, Tsirakis G. Alexandrakis MG, et al. Among authors: kokonozaki m. J Cancer Res Clin Oncol. 2015 Aug;141(8):1503-9. doi: 10.1007/s00432-015-1952-z. Epub 2015 Mar 13. J Cancer Res Clin Oncol. 2015. PMID: 25773125

4

High density of tryptase-positive mast cells in patients with multiple myeloma: correlation with parameters of disease activity.

Devetzoglou M, Vyzoukaki R, Kokonozaki M, Xekalou A, Pappa CA, Papadopoulou A, Alegakis A, Androulakis N, Alexandrakis MG. Devetzoglou M, et al. Among authors: kokonozaki m. Tumour Biol. 2015 Nov;36(11):8491-7. doi: 10.1007/s13277-015-3586-9. Epub 2015 May 31. Tumour Biol. 2015. PMID: 26026586

5

Correlation of Mast Cell Density With Angiogenic Cytokines in Patients With Active Multiple Myeloma.

Vyzoukaki R, Tsirakis G, Pappa CA, Androulakis N, Kokonozaki M, Tzardi M, Alexandrakis MG. Vyzoukaki R, et al. Among authors: kokonozaki m. Clin Ther. 2016 Feb;38(2):297-301. doi: 10.1016/j.clinthera.2015.11.022. Epub 2015 Dec 28. Clin Ther. 2016. PMID: 26740291

6

Serum Levels of Soluble FLT3 Ligand in Patients with Active Multiple Myeloma Constitute Marker of Bone Marrow Plasma Cell Proliferative Activity.

Kokonozaki M, Kanellou P, Pappa CA, Vyzoukaki R, Sarantoulaki S, Stavroulaki E, Kyriakaki S, Alegakis A, Boula A, Alexandrakis MG. Kokonozaki M, et al. Crit Rev Oncog. 2017;22(3-4):255-262. doi: 10.1615/CritRevOncog.2018021355. Crit Rev Oncog. 2017. PMID: 29604902

7

Clinical significance of interleukin-22 in multiple myeloma.

Tsirakis G, Pappa CA, Kolovou A, Kokonozaki M, Neonakis I, Alexandrakis MG. Tsirakis G, et al. Among authors: kokonozaki m. Hematology. 2015 Apr;20(3):143-7. doi: 10.1179/1607845414Y.0000000182. Epub 2014 Jul 24. Hematology. 2015. PMID: 25055724

8

Mast cells influence the proliferation rate of myeloma plasma cells.

Pappa CA, Tsirakis G, Stavroulaki E, Kokonozaki M, Xekalou A, Konsolas I, Alexandrakis MG. Pappa CA, et al. Among authors: kokonozaki m. Cancer Invest. 2015 Apr;33(4):137-41. doi: 10.3109/07357907.2015.1008639. Epub 2015 Mar 4. Cancer Invest. 2015. PMID: 25738408

9

Activated Protein C-Resistance Determination and Vascular Access Thrombosis in Populations with High Prevalence of Factor V Leiden.

Androulakis NE, Tzenakis N, Nioti E, Spatharaki P, Vyzoukaki R, Papadopoulou A, Kokonozaki M, Alexandrakis MG. Androulakis NE, et al. Among authors: kokonozaki m. Nephron. 2015;131(1):5-10. doi: 10.1159/000434649. Epub 2015 Aug 15. Nephron. 2015. PMID: 26418867

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page